Regeneron Class Action: Join by March 10, 2025 – Contact Levi & Korsinsky
Investors in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) have until March 10, 2025, to join a class action lawsuit alleging securities fraud against the biotechnology giant. The lawsuit, spearheaded by the law firm Levi & Korsinsky, claims that Regeneron misled investors regarding pricing practices related to its blockbuster drug, Eylea, potentially violating federal regulations. Allegations Against … Read more